当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析 - 现金流量表

荣昌生物

(688331)

  

流通市值:146.41亿  总市值:508.66亿
流通股本:1.62亿   总股本:5.64亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,062,768,898.97475,062,495.731,496,544,541.191,097,729,076.75
  收到的税费返还3,199.681,051,545.2214,123,058.4414,112,207.51
  收到其他与经营活动有关的现金14,811,572.273,885,843.42121,832,252.34110,331,330.11
  经营活动现金流入小计1,077,583,670.92479,999,884.371,632,499,851.971,222,172,614.37
  购买商品、接受劳务支付的现金52,300,717.4613,281,935.21143,134,491.15103,969,884.33
  支付给职工以及为职工支付的现金531,384,544.56280,175,888.451,085,094,453.63837,884,001.41
  支付的各项税费76,394,469.6441,460,861.0674,347,927.9837,431,526.62
  支付其他与经营活动有关的现金663,043,194.53333,396,332.731,444,226,492.411,077,990,268.89
  经营活动现金流出小计1,323,122,926.19668,315,017.452,746,803,365.172,057,275,681.25
  经营活动产生的现金流量净额-245,539,255.27-188,315,133.08-1,114,303,513.2-835,103,066.88
二、投资活动产生的现金流量:
  收回投资收到的现金250,000,000150,000,0001,000,000,000520,078,626.05
  取得投资收益收到的现金661,791.67177,6252,601,249.991,360,416.66
  处置固定资产、无形资产和其他长期资产收回的现金净额1,414,066.7395,0007,201,197.615,461,797.61
  收到的其他与投资活动有关的现金9,578,4009,578,40013,994,347.4413,994,347.44
  投资活动现金流入小计261,654,258.4159,851,0251,023,796,795.04540,895,187.76
  购建固定资产、无形资产和其他长期资产支付的现金120,552,809.8135,638,909.83265,281,866.7179,951,645.19
  投资支付的现金260,151,268.45151,000,0001,006,750,000786,750,000
  投资活动现金流出小计380,704,078.26186,638,909.831,272,031,866.7966,701,645.19
  投资活动产生的现金流量净额-119,049,819.86-26,787,884.83-248,235,071.66-425,806,457.43
三、筹资活动产生的现金流量:
  吸收投资收到的现金774,817,264.93232,945.361,032,897.911,032,897.91
  取得借款收到的现金1,198,221,840.57530,463,578.441,804,572,341.411,315,592,447.57
  收到其他与筹资活动有关的现金1,836,362.93---
  筹资活动现金流入小计1,974,875,468.43530,696,523.81,805,605,239.321,316,625,345.48
  偿还债务支付的现金1,018,225,763.78316,006,600.73257,688,039.441,569,400
  分配股利、利润或偿付利息支付的现金41,858,938.5723,994,702.4269,826,300.8453,218,519.45
  支付其他与筹资活动有关的现金34,454,700.6313,971,255.6285,122,094.9659,778,979.19
  筹资活动现金流出小计1,094,539,402.98353,972,558.77412,636,435.24114,566,898.64
  筹资活动产生的现金流量净额880,336,065.45176,723,965.031,392,968,804.081,202,058,446.84
四、汇率变动对现金及现金等价物的影响-4,276,762.99-2,367,997.432,547,892.84-5,694,629.93
五、现金及现金等价物净增加额511,470,227.33-40,747,050.3132,978,112.06-64,545,707.4
  加:期初现金及现金等价物余额759,530,043.42759,530,043.42726,551,931.36726,551,931.36
  期末现金及现金等价物余额1,271,000,270.75718,782,993.11759,530,043.42662,006,223.96
补充资料:
  净利润-449,568,663.07--1,468,360,802.55-
  资产减值准备--9,555,364.02-
  固定资产和投资性房地产折旧125,411,013.43-228,508,218.18-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧125,411,013.43-228,508,218.18-
  无形资产摊销4,149,416.39-7,538,995.87-
  长期待摊费用摊销2,001,255.77-5,584,443.58-
  待摊费用的减少--1,184,445.13-
  处置固定资产、无形资产和其他长期资产的损失-178,554.91-704,096.08-
  固定资产报废损失48,950.98-225,093.39-
  公允价值变动损失-52,149.71--1,537,475.88-
  财务费用45,927,831.76-71,281,059.57-
  投资损失4,433,931.62--2,404,171.3-
  存货的减少18,121,441.28-72,384,239.6-
  经营性应收项目的减少56,657,676.2--333,326,264.25-
  经营性应付项目的增加-91,496,853.28-152,463,841.12-
  其他12,139,512.52---
  现金的期末余额1,271,000,270.75-759,530,043.42-
  减:现金的期初余额759,530,043.42-726,551,931.36-
  现金及现金等价物的净增加额511,470,227.33-32,978,112.06-
公告日期2025-08-232025-04-292025-03-282024-10-30
审计意见(境内)标准无保留意见
TOP↑